Skip to main content
. 2020 Sep 17;18(9):e06223. doi: 10.2903/j.efsa.2020.6223

Table 17.

Summarising statistics describing serum concentrations of perfluoroalkyl sulfonic acids (PFSAs) and other selected PFASs in the European adult population based on studies included in Table B.2 and B.3 in Appendix B (from 2007–2008 and onwards)

Concentration (ng/mL)
PFBS PFHxS PFHpS PFOSa PFDS FOSA FOSA whole blood 8:2 monoPAP 8:2 diPAP EtFOSA EtFOSAA FC‐807 PFOSI
Statistics based on medians reported in studies included in Tables B.2 and B.3 in Appendix B, b Median 0.03 0.67 0.20 7.7 0.03 0.025 0.140 0.045 0.009 0.025
Mean 0.03 4.94 0.25 7.5 0.03 0.023 0.140 0.045 0.009 0.025
Minimum 0.03 0.20 0.08 1.7 0.01 0.007 0.140 0.045 0.009 0.004
Maximum 0.04 152 0.6 27.4 0.06 0.035 0.14 0.045 0.009 0.045
Number of studies c 2 37 8 32 2 4 1 1 1 2 0 0 0
Information based on individual samples reported in studies included in Tables B.2 and B.3 in Appendix B Minimum individual samples 0.006 0.008 0.05 0.06 0.005 0.0018 0.05 0.045 0.0005 0.004 0.27 0.0004 0.15
Maximum individual samples 4.6 1790 13.3 392.3 0.245 0.52 2.35 0.045 0.11 0.05 0.27 0.0007 NR
Country reporting maximum individual samples Italy Sweden France France Czech Republic Sweden Norway Norway Norway Norway Spain Germany Denmark
Reference for maximum Ingelido et al. (2018) Li et al. (2018a) Denys et al. (2014) Denys et al. (2014) Sochorová et al. (2017) Stubleski et al. (2016) Poothong et al. (2017) Poothong et al. (2017) Poothong et al. (2017) Haug et al. (2011b) Bartolome et al. (2017) Yeung et al. (2013b) Joensen et al. (2013)

NR: not reported; LOQ: limit of quantification.

For studies with median concentration lower than LOQ, the LOQ was used for calculations. For studies reporting the concentrations in ng/g, it was assumed that 1 g = 1 mL of serum/plasma.

a

Data from EFSA CONTAM Panel (2018) Opinion.

b

Based only on studies where median levels were reported.

c

Only studies where median is > LOQ are included in this number.